| 產(chǎn)品名稱 | Hydroxy-DPAT hydrobromide, (R)-(+)-7- - DPAT, (R)-7-OH- |
| 產(chǎn)品貨號 | Axon 1013 CAS [1021878-34-1] MF C16H25NO.HBrMW 328.29 Purity: 98% Optical purity: 98% ee Soluble in DMSO Description A Putative D3 dopamine receptor agonist (D3>D2>>D4 and D1); more active enantiomer of 7-OH-DPAT (Axon 1012), in comparison with (S)-(-)-7-OH-DPAT (Axon 1014) References Certificates Categories Extra info G Damsma et al. Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 ligand. Eur. J. Pharmacol. 1993, 249, R9-R10. ? LM?Pritchard?et al.?7-OH-DPAT and PD 128907 Selectively Activate the D3 Dopamine Receptor in a Novel Environment.?Neuropsychopharmacology?2003, 28, 100–107. ? Seeman and Van Tol. Dopamine receptor pharmacology. TiPS 1994, 15, 264. ? Certificate of Analysis Material Safety Data Sheet CNS D3 A17 D3 agonist Chemical name (R)-7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-2-ol hydrobromide Parent CAS No. [82730-72-1] Inquire |
| 產(chǎn)品價格 | 現(xiàn)貨詢價,電話:010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Hydroxy-DPAT hydrobromide, (R)-(+)-7- - DPAT, (R)-7-OH-Axon 1013 CAS [1021878-34-1] MF C16H25NO.HBr
Description?
D3 agonist
Chemical name(R)-7-Dipropylamino-5,6,7,8-tetrahydro-naphthalen-2-ol hydrobromide Parent CAS No.[82730-72-1] |
| 產(chǎn)品資料 |